Filing Details
- Accession Number:
- 0001179110-13-015804
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-10-29 16:35:23
- Reporting Period:
- 2013-10-25
- Filing Date:
- 2013-10-29
- Accepted Time:
- 2013-10-29 16:35:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1113481 | Medicines Co | MDCO | Pharmaceutical Preparations (2834) | 043324394 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1277478 | Glenn Sblendorio | 8 Sylvan Way Parsippany NJ 07054 | President & Cfo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2013-10-25 | 574 | $35.89 | 120,072 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-10-25 | 25,000 | $17.04 | 145,072 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-10-25 | 25,000 | $35.69 | 120,072 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Option (Right-to-buy) | Disposition | 2013-10-25 | 25,000 | $0.00 | 25,000 | $17.04 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2017-07-12 | No | 4 | M | Direct |
Footnotes
- The range of prices for the transactions reported on this line is between $35.40 and $36.00 per share. The price reported above reflects the weighted average sales price. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full informaton regarding the number of shares sold at each separate price.
- As of October 29, 2013, the original grant (25,000 shares granted on July 12, 2007) was fully vested. After the exercise of the options reported hereby, there are no remaining shares covered by this option.